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An iron–oxygen intermediate formed during the
catalytic cycle of cysteine dioxygenase†
E. P. Tchesnokov,a A. S. Faponle,b C. G. Davies,a M. G. Quesne,b R. Turner,c
M. Fellner,a R. J. Souness,a S. M. Wilbanks,d S. P. de Visser*b and G. N. L. Jameson*a
Cysteine dioxygenase is a key enzyme in the breakdownof cysteine, but
its mechanism remains controversial. A combination of spectroscopic
and computational studies provides the first evidence of a short-lived
intermediate in the catalytic cycle. The intermediate decays within
20 ms and has absorption maxima at 500 and 640 nm.
Cysteine dioxygenase (CDO) catalyzes the first irreversible step
in cysteine dissimilation through various pathways to taurine,
pyruvate and sulfate.1–3 The substrate of CDO, cysteine, is a non-
essential amino acid building block for protein biosynthesis and
is an excitotoxic agent in the nervous system.4,5 The neuro-
excitatory properties of cysteine implicate cysteine levels, and
thus CDO function, in neurodegenerative diseases.6,7 However,
recent findings by Brait et al. broadened this narrow apprecia-
tion of the pathological roles of cysteine and CDO by showing
that forced expression of the CDO gene in human cancer cells
markedly decreased tumor cell growth.8
CDO has unusual structural features thatmake it of great interest
when trying to understand the factors that control iron–dioxygen
chemistry.9,10 The octahedral ferrous iron is coordinated by three
histidines rather than the more usual 2-His/1-carboxylate motif that
is common in non-heme mononuclear iron enzymes. The neutral
coordination of the protein observed in CDO is expected to affect
individual reaction steps through stabilization of negative charge.11
The mechanism of CDO has been investigated computation-
ally by one of us.12,13 These results showed that cysteine-bound
CDO binds dioxygen to form an iron(III)–superoxo species that
attacks the bound sulfur of cysteine by the distal oxygen of
superoxide (Scheme 1). Heterogeneous O–O bond cleavage leads
to formation of an iron(IV)–oxo intermediate that supplies the
second O atom to sulfur. This mechanism has been supported
by combined spectroscopic and computational studies of small
molecule biomimetic complexes of CDO some of which show
formation of an iron(IV)–oxo intermediate.14–16 Here we report a
single turnover approach allowing direct comparison of our
experimental results to computational findings.
First the stability and spectroscopic description of the cysteine-
bound complex was explored byMo¨ssbauer spectroscopy. This was to
find conditions under which single turnover experiments would be
successful and to aid interpretation of freeze-quench experiments
(vide infra) where the redox state of the iron during turnover could be
probed. In this studywe titrated cysteine with CDO at 20 and 4 1Cand
measured Mo¨ssbauer spectral changes. We were able to show that
CDO forms a stoichiometric and stable active complex with cysteine.
Scheme 1 Catalytic cycle of CDO.
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Careful deconvolution of a large number of Mo¨ssbauer
spectra (n = 17) showed that the signal corresponding to resting
state CDO disappeared with concomitant formation of two new
sub-spectra characterized by similar isomer shifts but diﬀering
quadrupole splittings (see ESI†). It can be seen that one of the
species has parameters very similar to resting state CDO and
was indeed wrongly attributed to unbound resting state CDO in
our previous paper upon addition of 10 mM cysteine.10 We
investigated whether the two sub-spectra could be caused by
the presence or absence of the cysteine–tyrosine posttranslational
crosslink found in close proximity to the iron.9 However, this
is not the case. The C93G variant displays multiple turnover
kinetics similar to wild-type enzyme17 and produces the same two
Mo¨ssbauer sub-spectra as does wild-type CDO (ESI†) even though
it is unable to form the crosslink. Indeed, observation of two
Mo¨ssbauer sub-spectra upon substrate binding has been noted
before for other non-heme mononuclear iron enzymes.18,19
Computational prediction of Mo¨ssbauer parameters has allowed
us to assign the two sub spectra to cysteine bound CDOwith (A) and
without (A0) a bound water (Scheme 1 and ESI†). This designation
is further supported by recent crystallographic evidence for (A) in
a C164S variant of CDO.20
The proportion of cysteine-bound species was determined
directly from the spectra and plotted versus the concentration of
cysteine added, normalized to active site iron present (Fig. S4, ESI†).
Fitting these data to standard equations yielded a CDO:FeII:cysteine
complex dissociation constant, KD, of 65  20 mM. Because this
is well below the concentration of CDO and cysteine used in
data collection, it represents an upper limit but confirms
relatively tight binding of cysteine. These samples were then
exposed to air to check that they were catalytically competent by
monitoring the appearance of cysteine sulfinic acid (CSA)
product by HPLC and MS analysis (ESI†). The amount of CSA
produced was stoichiometric with respect to the concentration
of CDO:FeII:cysteine complex.
The production and isolation of a catalytically active cysteine-
bound species allowed the dioxygenation reaction of cysteine
dioxygenase to be studied. We initially measured UV/vis spectral
changes of anaerobic CDO:FeII:cysteine complex after mixing
with degassed and oxygenated buﬀer but only observed changes
when the temperature was lowered to 4 1C (Fig. 1a). No spectral
changes could be observed after mixing with degassed buﬀer
showing that our procedures were strictly anaerobic. However,
CDO:FeII:cysteine complex mixed with oxygenated buﬀer exhibited
formation of two absorption maxima (500 and 640 nm) and a
shoulder at 350 nm within the mixing time of the apparatus
(B1 ms). The absorption was proportional to the amount of
enzyme used and dioxygen added. These absorption features
disappeared within approximately 20 ms with a first order rate
constant of 112  5 s1 which is independent of oxygen
concentration (Fig. 1b–e). This indicated that the species is
an oxygen adduct of CDO.
Fig. 1 Production of a catalytically competent intermediate during single turnover of CDO. (a) Transient absorption spectrum of the intermediate
formed within mixing (blue) disappears within 20 ms (b). The amount of intermediate is dependent upon the amount of protein (500 (red) and 240 mM
(black) CDO:cysteine complex) (c) and dioxygen (d). The rate of decay is independent of the dioxygen concentration (e). Chemical quench with HCl
showsB85% cysteine (blue) is recovered under anaerobic mixing while most CSA (B70%, green) is produced within 20 ms suggesting the intermediate is
on-pathway (f). Mo¨ssbauer spectrum of the Fe(II) resting state; anaerobic mixing followed by freeze-quench recovers the cysteine bound ES complex;
freeze-quench after mixing with dissolved oxygen recovered the Fe(II) resting state (g).
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Chemical quench experiments using HCl as quenching agent
allowed us to investigate whether the intermediate was on-pathway
(Fig. 1f). Two independent experiments involving diﬀerent enzyme
preparations showed no CSA could be detected in CDO:FeII:cysteine
containing samples quenched anaerobically, while the recovery of
unused cysteine substrate was near stoichiometric (87 7%, n = 7).
CDO:FeII:cysteine mixed with oxygenated buﬀer for 20 ms and
quenched showed high conversion to CSA (67  7%, n = 5).
Importantly, unreacted cysteine was not detectable strongly
supporting complete turnover. Indeed, the slightly lower value
of conversion is probably caused by precipitation of CSA during
acid quenching and this is supported by essentially identical
recoveries from samples quenched after longer (minute) reaction
times (74  9%, n = 3).
The reaction was further investigated by freeze-quench studies.
Mixture of anaerobic cysteine-bound CDO with stoichiometric
amounts of dioxygen (supplied as oxygenated buﬀer) at 4 1C
followed by quenching through freezing in 2-methylbutane after
10 and 20 ms gave Mo¨ssbauer spectra consistent with pure
resting state CDO (Fig. 1g). The return of the chemical system
to resting state within a time period of 20 ms implicates a fast
dioxygenation step with a second order reaction rate constant of
Z3  105 M1 s1 and quite possibly even faster.
To confirm that turnover occurred in these samples, they
were subsequently thawed under strict anaerobic conditions
inside the glove box. Thereafter, the sample was tested for the
presence of CSA and near stoichiometric amounts of CSA were
determined by mass spectrometry (652 mM CDO:FeII:cysteine
produced 573 mM CSA, 88% conversion). In a completely
independent replicate experiment involving an entirely diﬀerent
enzyme preparation, a 92% turnover was determined using
HPLC-evaporative light scattering (ELSD) analysis.
Unfortunately, our attempts to definitively spectroscopically
characterize the colored intermediate by other means were
unsuccessful. Freeze-quench down to B10 ms did not show
Mo¨ssbauer spectra widely diﬀerent from resting state and our
C93G variant showed a similar intermediate that decayed even
faster (see ESI†). Importantly, however, our studies highlight that
presence of cysteine 93 as a free thiol (rather than being cross-
linked with tyrosine 157) slows the reaction. This is consistent
with our previous investigations17 and explains why crosslink
formation increases activity.
In order to gain insight into the structure and properties
of this short-lived intermediate, we decided to use DFT and
ab initio (CASSCF/NEVPT2) methods to probe possible candidates.
Our computational methods were calibrated and benchmarked
previously and shown accurately to reproduce experimental
resonance Raman spectra, infrared spectra as well as kinetic
isotope eﬀects and rate constants excellently.21,22 We initially
took the DFT optimized geometries of catalytic cycle intermedi-
ates with two oxygen atoms included from previous studies12
and after reoptimizing with the methods described in the ESI†
analyzed the absorption spectra for each species in the triplet
and quintet spin states using various methods and basis sets.
The focus of the calculations was on the iron(III)–superoxo (B),
iron(III)-bicyclic ring-structure (C), iron(IV)–oxo–cysteinesulfoxide
complex (D and D0) as well as the iron(III)–cysteine–sulfinic acid
product complex (E). To complement the series and confirm that
the signals correspond to post-oxygen binding, also several
catalytic cycle intermediates not previously considered yet were
investigated, e.g. the A and A0 described above. In addition,
CASSCF(10,14)/NEVPT2/BS2 calculations on 5B and 5C were
performed.
Fig. 2 shows calculated absorption spectra of key catalytic
intermediates and the potential energy landscape. The rate
determining barrier is the attack of the superoxo on sulfur to
form a bicyclic ring structure with an activation barrier of
10.0 kcal mol1 (DG‡ = 13.4 kcal mol1) in the quintet spin
state. Note that the first two reaction barriers are relatively high
in energy (10.0 and 8.2 kcal mol1 with respect to their
precursors) and as such both 5B and 5C should have a finite
lifetime, whereas all other quintet intermediates will be short-
lived and most likely too short to detect. As such, based on the
energy landscape there are only two likely candidates for the
UV/Vis absorption features in Fig. 1, namely 5B and 5C as they
are located in a potential well.
An analysis of the TD-DFT calculated absorption spectra of
all species shows that very few structures give patterns in the
400–700 nm range that match the experimental spectrum of
Fig. 1a. However, there is some degree of variation between
different methods and basis sets. Nevertheless with all methods
applied we find several absorption bands in the 400–700 nm
range for the bicyclic ring-structure (C) in the quintet spin state.
This structure gives maxima in the absorption spectrum at 552
and 661 nmwith TD-DFT/BS1, 562 and 630 nmwith TD-DFT/BS2
and 543 and 644 nm with CASSCF(10,14)/BS2; all of which are in
good qualitative agreement with the maxima seen in Fig. 1a and
are consistent with the fact that DFT tends to overestimate
absorption and frequency bands by 5–10%. These bands refer
to excitation of an electron from the p*OO,x orbital into the S–O
antibonding orbital (562 nm transition) or from the p*yz orbital
on iron to the O–O antibonding (s) orbital (630 nm transition).
In contrast, no absorption maxima between 400 and 700 nm
could be found for the iron(III)–superoxo structure, the cysteine
sulfoxide (D and D0) nor the cysteine sulfinic acid (E).
Fig. 2 Potential energy profile with energies in kcal mol1 of cysteine
dioxygenation by CDO models as calculated with B3LYP/BS2//B3LYP/BS1.
Insets show calculated (TD-DFT/BS2 and CASSCF/BS2) absorption spectra
of local minima.
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Despite the fact that the TD-DFT calculated spectra of the ferric
superoxide 5B give no significant absorption patterns in the 400–
700 nm range, at CASSCF level of theory two bands appear, although
significantly shifted with respect to those obtained experimentally.
Therefore, although we cannot rule 5B out entirely, the most likely
structure that contributes to the experimental absorption spectrum
is the bicyclic ring structure in the quintet spin state (C). We
tried to confirm this by other means. Freeze-quench down to
10 ms shows a Mo¨ssbauer spectrum that is very close to resting
state (Fig. 1g). Calculated Mo¨ssbauer parameters (ESI†) for all
the species suggests that both the ferric superoxide and bicyclic
system have similar Mo¨ssbauer parameters to resting state and
thus, unfortunately, the current data is not conclusive but
describes our current best understanding.
The typical 3-His coordination of CDO, rather than the 2-His/
1-carboxylate ligand system in most non-heme iron dioxygenases
may be responsible for the enhanced stability of the bicyclic ring
structure and its relative large barrier to convert to an iron(IV)–oxo
intermediate. This may give it a slightly longer lifetime in CDO than
in alternative non-heme iron dioxygenases. For example, a related
bicyclic intermediate in homoprotocatechuate 2,3-dioxygenase
(2,3-HPCD) has been observed crystallographically but not spectro-
scopically characterized.23,24 Likewise, in TauD25,26 the barrier to
O–O bond scission is 3.6 kcal mol1 and this explains why this
intermediate is not observed during freeze-quench studies.27
The fact that an intermediate is observable in CDO, although
only transiently, suggests that through suitable modification of
the active site this intermediate might be further stabilized and
such studies are underway in our laboratories. With observation
of this intermediate we have experimental evidence to support
the mechanism of CDO previously proposed.12,13 We also have
initial spectroscopic evidence for iron–oxygen attack on a thiol at
a non-heme mononuclear-iron enzyme.
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